BTIG initiates Hershey stock coverage with neutral rating By Investing.com

BTIG initiated Hershey (HSY) at Neutral, citing attractive cost/price dynamics and international improvement potential but also consumer headwinds and an uncertain volume trajectory. The firm’s 12-month forward EPS estimate is about 1% above 2026 consensus and 3% to 4% above 2027-2028 consensus, while the stock trades at an implied 23x forward EPS, above its 20-year average and near its 10-year average. Hershey also highlighted 15% to 20% EPS growth targets by 2027, but several brokers have trimmed price targets on valuation concerns.

Analysis

HSY is in the awkward middle zone where fundamentals are no longer deteriorating fast enough to justify panic, but not strong enough to merit multiple expansion. The key issue is that the market is still paying for “defensive compounding” while the business is behaving more like a mature consumer staple with cyclical volume risk, so any shortfall in elasticity or mix can compress the forward multiple quickly. That makes the stock more sensitive to unit trends than to headline EPS, because cost leverage can mask weaker demand for a few quarters before the market reprices the durability of growth.

The second-order effect is on capital allocation: if promotional intensity stays lower across packaged foods, HSY may preserve margin near term, but it also risks ceding shelf velocity and household penetration to private label or better-promoted snack peers. International improvement is a real optionality lever, but it is likely a 12-24 month story and requires execution in distribution and product localization; it won’t rescue the next couple of quarters if U.S. volume remains soft. In other words, the stock’s upside is increasingly dependent on a clean demand inflection, not just margin management.

The contrarian read is that valuation may not be as “cheap” as bulls argue because the market is anchoring to a normalized earnings stream that may itself prove too high if volume weakness persists. The dividend and brand quality support the downside, but they do not eliminate the risk of a prolonged multiple de-rating if investors conclude HSY is a low-growth cash return vehicle rather than a growth compounder. Near term, the biggest catalyst is not guidance optimism but evidence that household demand stabilized through the next two reporting cycles.

Key Decisions for Investors

• Avoid initiating fresh long exposure in HSY until the next two monthly sell-through reads confirm volume stabilization; the risk/reward is poor if the market re-rates the stock from a premium staple multiple to a lower-growth consumer name.
• For existing longs, consider a collar: long HSY equity vs. short-dated out-of-the-money calls financed by puts 5-10% below spot, targeting the next 1-2 quarters to protect against a multiple reset while preserving dividend carry.
• Pair trade: long defensive staples with cleaner volume momentum (e.g., GIS/K) and short HSY over the next 3-6 months if you expect promotional pressure and softer elasticity to show up in U.S. scanner data.
• If you want to express the bearish view more efficiently, use HSY put spreads 1-2 earnings cycles out; the cleanest payoff is on a guidance-to-volume miss, not on a collapse in intrinsic value.
• Revisit a long only after evidence of sustained unit recovery or a 10-15% de-rating in the share price; that would improve the margin of safety and reduce the probability of buying peak sentiment on the cost story.